New papulovesicular rash in the course of COVID-19 signaling viral reactivation
AUTOR(ES)
Rihl, Marcos Frata; Fendt, Lúcia Costa Cabral; Nedel, Wagner Luis
FONTE
Rev. Assoc. Med. Bras.
DATA DE PUBLICAÇÃO
2021-02
RESUMO
SUMMARY Cutaneous manifestations are considered an infrequent presentation of coronavirus disease 2019 (COVID-19) and are mostly described in outpatient settings. Its onset during the course of the severe COVID-19 disease has been poorly described in severe cases. Studies focused on dermatological manifestations mostly described maculopapular or pernio-like lesions and less frequently vesicular or varicella-like eruption. We described the occurrence of a vesiculopapular eruption in three laboratory-confirmed COVID-19 patients associated with severe lung injury in whom the skin findings preceded viral reactivation and recrudescence of hypoxemia. The potential mechanisms for COVID-19-related cutaneous manifestations include immune hypersensitivity, cytokine-release syndrome, deposition of microthrombi, and vasculitis.
Documentos Relacionados
- A case of COVID-19 with papulovesicular rash that progressed to retiform purpura, accompanied by cherry angiomas
- Post-COVID-19 Syndrome? New daily persistent headache in the aftermath of COVID-19
- New challenges for lung transplantation in the era of COVID-19
- Percutaneous tracheostomy in COVID-19 patients: a new apneic approach
- Second COVID-19 infection in a patient with multiple myeloma in Brazil - reinfection or reactivation?